MAKING NANOPHARMACEUTICALS BIG

Owners

Goods & Services

diagnostic and prognostic preparations for clinical or medical laboratory use; diagnostic and prognostic reagents for identifying a disease or disorder and/or the progression of a disease or disorder

Medical and scientific research services, namely, research, development, analytical, formulation, and product development services in the pharmaceutical field

Pharmaceutical preparations for use in the diagnosis, prognosis, and treatment of oncological diseases or disorders; pharmaceutical preparations for use in the diagnosis, prognosis, and treatment of pre-cancerous diseases or disorders; pharmaceutical preparations for use in the diagnosis, prognosis, and treatment of benign and malignant cancers or neoplasms; pharmaceutical preparations for use in the diagnosis, prognosis, and treatment of inflammation and inflammatory diseases or disorders; pharmaceutical preparations for use in the diagnosis, prognosis, and treatment of cardiovascular diseases or disorders; pharmaceutical preparations for use in modulating angiogenesis; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations, namely, drug delivery systems that contain compounds which facilitate the delivery of a wide range of pharmaceuticals; pharmaceutical preparations, namely, drug delivery systems that contain nanometer scale or nanometer size compounds which facilitate the delivery of a wide range of pharmaceuticals; pharmaceutical preparations, namely, drug delivery systems that contain polymer and/or lipid based compounds for controlled release of a wide range of pharmaceuticals; pharmaceutical preparations for the treatment of oncological diseases or disorders comprising a pharmaceutical included with a nanometer-sized composition which facilitates the delivery and/or the controlled release of the pharmaceutical; pharmaceutical preparations for the treatment of pre-cancerous diseases or disorders comprising a pharmaceutical included with a nanometer-sized composition which facilitates the delivery and/or the controlled release of the pharmaceutical; pharmaceutical preparations for the treatment of benign and malignant cancers or neoplasms comprising a pharmaceutical included with a nanometer-sized composition which facilitates the delivery and/or the controlled release of the pharmaceutical; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases or disorders comprising a pharmaceutical included with a nanometer-sized composition which facilitates the delivery and/or the controlled release of the pharmaceutical; pharmaceutical preparations for the treatment of cardiovascular diseases or disorders comprising a pharmaceutical included with a nanometer-sized composition which facilitates the delivery and/or the controlled release of the pharmaceutical